Literature DB >> 16243295

Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells.

Tania Yasmin1, Fumi Takahashi-Yanaga, Jun Mori, Yoshikazu Miwa, Masato Hirata, Yutaka Watanabe, Sachio Morimoto, Toshiyuki Sasaguri.   

Abstract

To determine the mechanism by which differentiation-inducing factor-1 (DIF-1), a morphogen of Dictyostelium discoideum, inhibits tumor cell proliferation, we examined the effect of DIF-1 on the gene expression of cyclin D1. DIF-1 strongly reduced the expression of cyclin D1 mRNA and correspondingly decreased the amount of beta-catenin in HeLa cells and squamous cell carcinoma cells. DIF-1 activated glycogen synthase kinase-3beta (GSK-3beta) and inhibition of GSK-3beta attenuated the DIF-1-induced beta-catenin degradation, indicating the involvement of GSK-3beta in this effect. Moreover, DIF-1 reduced the activities of T-cell factor (TCF)/lymphoid enhancer factor (LEF) reporter plasmid and a reporter gene driven by the human cyclin D1 promoter. Eliminating the TCF/LEF consensus site from the cyclin D1 promoter diminished the effect of DIF-1. These results suggest that DIF-1 inhibits Wnt/beta-catenin signaling, resulting in the suppression of cyclin D1 promoter activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243295     DOI: 10.1016/j.bbrc.2005.10.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.

Authors:  Wen Liang Pan; Jack Ho Wong; Evandro Fei Fang; Yau Sang Chan; Tzi Bun Ng; Randy Chi Fai Cheung
Journal:  Biochem Pharmacol       Date:  2014-03-14       Impact factor: 5.858

2.  P120ctn overexpression enhances beta-catenin-E-cadherin binding and down regulates expression of survivin and cyclin D1 in BEL-7404 hepatoma cells.

Authors:  Chao-Zan Nong; Li-Li Pan; Wei-Sheng He; Xi-Liang Zha; Hai-Hong Ye; Hua-Yi Huang
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

3.  Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway.

Authors:  Tatsuya Yoshihara; Fumi Takahashi-Yanaga; Fumie Shiraishi; Sachio Morimoto; Yutaka Watanabe; Masato Hirata; Sumio Hoka; Toshiyuki Sasaguri
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

4.  Reduced amyloidogenic processing of the amyloid beta-protein precursor by the small-molecule Differentiation Inducing Factor-1.

Authors:  Michael A Myre; Kevin Washicosky; Robert D Moir; Giuseppina Tesco; Rudolph E Tanzi; Wilma Wasco
Journal:  Cell Signal       Date:  2008-12-25       Impact factor: 4.315

Review 5.  Dictyostelium: An Important Source of Structural and Functional Diversity in Drug Discovery.

Authors:  Yuzuru Kubohara; Haruhisa Kikuchi
Journal:  Cells       Date:  2018-12-21       Impact factor: 6.600

6.  Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis.

Authors:  Fumi Tetsuo; Masaki Arioka; Koichi Miura; Misato Kai; Momoko Kubo; Kazunobu Igawa; Katsuhiko Tomooka; Fumi Takahashi-Yanaga; Fusanori Nishimura; Toshiyuki Sasaguri
Journal:  Cancer Sci       Date:  2019-10-26       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.